Literature DB >> 20702408

CCAAT/enhancer-binding protein β and NF-κB mediate high level expression of chemokine genes CCL3 and CCL4 by human chondrocytes in response to IL-1β.

Zhiqi Zhang1, Jennifer L Bryan, Elizabeth DeLassus, Li-Wei Chang, Weiming Liao, Linda J Sandell.   

Abstract

A large set of chemokines is highly up-regulated in human chondrocytes in response to IL-1β (Sandell, L. J., Xing, X., Franz, C., Davies, S., Chang, L. W., and Patra, D. (2008) Osteoarthr. Cartil. 16, 1560-1571). To investigate the mechanism of transcriptional regulation, deletion constructs of selected chemokine gene promoters, the human CCL3 (MIP-1α) and CCL4 (MIP-1β), were transfected into human chondrocytes with or without IL-1β. The results show that an IL-1β-responsive element is located between bp -300 and -140 of the CCL3 promoter and between bp -222 and -100 of the CCL4 promoter. Because both of these elements contain CCAAT/enhancer-binding protein β (C/EBPβ) motifs, the function of C/EBPβ was examined. IL-1β stimulated the expression of C/EBPβ, and the direct binding of C/EBPβ to the C/EBPβ motif was confirmed by EMSA and ChIP analyses. The -300 bp CCL3 promoter and -222 bp CCL4 promoter were strongly up-regulated by co-transfection with the C/EBPβ expression vector. Mutation of the C/EBPβ motif and reduction of C/EBPβ expression by siRNA decreased the up-regulation. Additionally, another cytokine-related transcription factor, NF-κB, was also shown to be involved in the up-regulation of chemokines in response to IL-1β, and the binding site was identified. The regulation of C/EBPβ and NF-κB was confirmed by the inhibition by C/EBPβ and NF-κB and by transfection with C/EBPβ and NF-κB expression vectors in the presence or absence of IL-1β. Taken together, our results suggest that C/EBPβ and NF-κB are both involved in the IL-1β-responsive up-regulation of chemokine genes in human chondrocytes. Time course experiments indicated that C/EBPβ gradually and steadily induces chemokine up-regulation, whereas NF-κB activity was highest at the early stage of chemokine up-regulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20702408      PMCID: PMC2963416          DOI: 10.1074/jbc.M110.130377

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

Review 1.  Chemokines and disease.

Authors:  C Gerard; B J Rollins
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

2.  Dynamic regulation of cyclooxygenase-2 promoter activity by isoforms of CCAAT/enhancer-binding proteins.

Authors:  Ying Zhu; Michael A Saunders; Howard Yeh; Wu-guo Deng; Kenneth K Wu
Journal:  J Biol Chem       Date:  2001-12-10       Impact factor: 5.157

3.  Interleukin-1-mediated stabilization of mouse KC mRNA depends on sequences in both 5'- and 3'-untranslated regions.

Authors:  J M Tebo; S Datta; R Kishore; M Kolosov; J A Major; Y Ohmori; T A Hamilton
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

4.  Surfactant protein D gene regulation. Interactions among the conserved CCAAT/enhancer-binding protein elements.

Authors:  Yanchun He; Erika Crouch
Journal:  J Biol Chem       Date:  2002-03-23       Impact factor: 5.157

5.  Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand.

Authors:  J H Han; S J Choi; N Kurihara; M Koide; Y Oba; G D Roodman
Journal:  Blood       Date:  2001-06-01       Impact factor: 22.113

Review 6.  The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus.

Authors:  D M Rothwarf; M Karin
Journal:  Sci STKE       Date:  1999-10-26

7.  Ligation of CD11b and CD11c beta(2) integrins by antibodies or soluble CD23 induces macrophage inflammatory protein 1alpha (MIP-1alpha) and MIP-1beta production in primary human monocytes through a pathway dependent on nuclear factor-kappaB.

Authors:  R Rezzonico; V Imbert; R Chicheportiche; J M Dayer
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

8.  CCAAT/enhancer-binding proteins beta and delta mediate the repression of gene transcription of cartilage-derived retinoic acid-sensitive protein induced by interleukin-1 beta.

Authors:  Ken Okazaki; Jian Li; Hua Yu; Naoshi Fukui; Linda J Sandell
Journal:  J Biol Chem       Date:  2002-06-18       Impact factor: 5.157

9.  AML-1A and AML-1B regulation of MIP-1alpha expression in multiple myeloma.

Authors:  Sun J Choi; Tomoko Oba; Natalie S Callander; Diane F Jelinek; G David Roodman
Journal:  Blood       Date:  2003-01-30       Impact factor: 22.113

10.  IKKbeta activation is sufficient for RANK-independent osteoclast differentiation and osteolysis.

Authors:  Jesse E Otero; Simon Dai; Muhammad A Alhawagri; Isra Darwech; Yousef Abu-Amer
Journal:  J Bone Miner Res       Date:  2010-06       Impact factor: 6.741

View more
  33 in total

1.  TGR5 reduces macrophage migration through mTOR-induced C/EBPβ differential translation.

Authors:  Alessia Perino; Thijs Willem Hendrik Pols; Mitsunori Nomura; Sokrates Stein; Roberto Pellicciari; Kristina Schoonjans
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

2.  Hybrid Mouse Diversity Panel Identifies Genetic Architecture Associated with the Acute Antisense Oligonucleotide-Mediated Inflammatory Response to a 2'-O-Methoxyethyl Antisense Oligonucleotide.

Authors:  Elaine Pirie; Patrick Cauntay; Wuxia Fu; Shayoni Ray; Calvin Pan; Aldonis J Lusis; Jill Hsiao; Sebastien A Burel; Padma Narayanan; Rosanne M Crooke; Richard G Lee
Journal:  Nucleic Acid Ther       Date:  2019-08-01       Impact factor: 5.486

3.  Tumor necrosis factor α- and interleukin-1β-dependent induction of CCL3 expression by nucleus pulposus cells promotes macrophage migration through CCR1.

Authors:  Jianru Wang; Ye Tian; Kate L E Phillips; Neil Chiverton; Gail Haddock; Rowena A Bunning; Alison K Cross; Irving M Shapiro; Christine L Le Maitre; Makarand V Risbud
Journal:  Arthritis Rheum       Date:  2013-03

4.  Decreased 11β-hydroxysteroid dehydrogenase 1 in lungs of steroid receptor coactivator (Src)-1/-2 double-deficient fetal mice is caused by impaired glucocorticoid and cytokine signaling.

Authors:  Jingfei Chen; Ritu Mishra; Yaqin Yu; Jeffrey G McDonald; Kaitlyn M Eckert; Lu Gao; Carole R Mendelson
Journal:  FASEB J       Date:  2020-10-18       Impact factor: 5.191

5.  PKC-epsilon and TLR4 synergistically regulate resistin-mediated inflammation in human macrophages.

Authors:  Mary C Zuniga; Gayatri Raghuraman; Elizabeth Hitchner; Cornelia Weyand; William Robinson; Wei Zhou
Journal:  Atherosclerosis       Date:  2017-02-24       Impact factor: 5.162

6.  The chemokine receptor CCR5 plays a role in post-traumatic cartilage loss in mice, but does not affect synovium and bone.

Authors:  K Takebe; M F Rai; E J Schmidt; L J Sandell
Journal:  Osteoarthritis Cartilage       Date:  2014-12-09       Impact factor: 6.576

7.  Effects of CD14 macrophages and proinflammatory cytokines on chondrogenesis in osteoarthritic synovium-derived stem cells.

Authors:  Sun Ae Han; Sahnghoon Lee; Sang Cheol Seong; Myung Chul Lee
Journal:  Tissue Eng Part A       Date:  2014-07-22       Impact factor: 3.845

Review 8.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

9.  Hepatitis C virus infection induces inflammatory cytokines and chemokines mediated by the cross talk between hepatocytes and stellate cells.

Authors:  Hironori Nishitsuji; Kenji Funami; Yuko Shimizu; Saneyuki Ujino; Kazuo Sugiyama; Tsukasa Seya; Hiroshi Takaku; Kunitada Shimotohno
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

10.  Molecular characterization of articular cartilage from young adults with femoroacetabular impingement.

Authors:  Shingo Hashimoto; Muhammad Farooq Rai; Corey S Gill; Zhiqi Zhang; Linda J Sandell; John C Clohisy
Journal:  J Bone Joint Surg Am       Date:  2013-08-21       Impact factor: 5.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.